Medicis Pharmaceutical Corporation

MEDICIS PHARMACEUTICAL CORP Files SEC form 8-K, Completion of Acquisition or Disposition of...

yahoo.com     Jul 3, 2008   8 related          

| Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICIS PHARMACEUTICAL CORP Completion of Acquisition or Disposition of Assets Item 2.01. As previously reported, on June 16, 2008, Medicis Pharmaceutical Corporation...                

comments

                   

Female investing group learns from surroundings

rgj.com     Jun 28, 2008   1 related          

By Roseann Keegan • Special to • June 28, 2008 Sometimes smart investing comes down to paying attention to the world around you. For the eight members of the all-women Let it Ride Investors Club of Carson Valley, paying...                

comments

MEDICIS PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR...

yahoo.com     Jun 19, 2008          

| Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICIS PHARMACEUTICAL CORP Entry into a Material Definitive Agreement Item 1.01. On June 16, 2008, Medicis Pharmaceutical Corporation ("Medicis") entered into a definitive...                

comments

                   

Medicis To Acquire LipoSonix

medicaldesignonline.com     Jun 18, 2008   10 related          

Medicis and LipoSonix, Inc. jointly announced they have entered into a definitive merger agreement under which Medicis will acquire LipoSonix, an independent, privately-held company with a staff of approximately 40 scientists,...                

comments

Medicis Declares Cash Dividend

redorbit.com     Jun 11, 2008   4 related          

SCOTTSDALE, Ariz., June 11, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.04 per issued and outstanding share of its Common Stock payable on...                

comments

Perrigo Confirms Filing for Generic Version of VANOS(R) (PR Newswire)

yahoo.com     Jun 11, 2008   4 related          

Perrigo Company today announced that it has filed an Abbreviated New Drug Application for Fluocinonide Cream 0.1%, a generic version of VANOS® Cream 0.1%. The Company believes that it is the first to file an ANDA with a...                

comments

Medicis to Present At Goldman Sachs Global Healthcare Conference

redorbit.com     Jun 6, 2008   1 related          

Posted on: Friday, 6 June 2008, 09:01 CDT SCOTTSDALE, Ariz., June 6, 2008 (PRIME NEWSWIRE) -- This link will allow visitors to the website to access the Medicis presentation. An archive of the webcast will be available on the...                

comments

                   

Medicis Pharmaceutical Corporation Q1 2008 Earnings Call Transcript

pharmiweb.co.uk     May 31, 2008          

posted on: May 30, 2008 | about stocks: MRX Q1 2008 Earnings Call Transcript Executives Jonah Shacknai – Chairman and CEO Mark Prygocki – EVP and COO Ric Peterson – EVP, CFO and Treasurer Analysts James Kelly – Goldman Sachs Edmund...                

comments

Medicis to Present At Citi Investment Research Healthcare Conference

redorbit.com     May 19, 2008   3 related          

SCOTTSDALE, Ariz., May 19, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 2008 Citi Investment Research Global Healthcare Conference in New York City. A live webcast of its presentation scheduled for Wednesday, May 21, 2008, at 2:30 p.m.                

comments

Medicis Announces Voluntary Recall of Solodyn® (minocycline HCL, USP) 90 Mg Tablets, Extended...

recallinsider.com     May 19, 2008   1 related          

Medicis have announced that the Company is voluntarily recalling lot numbers B080037 (Exp: 12/09) and B080038 (Exp: 12/09) of the antibiotic SOLODYN® (minocycline HCl, USP) Extended Release Tablets, 90 mg, 30-count bottles (NDC 99207-461-30). Medicis has received a report that one bottle in lot...                

comments

1 2 3 next